Patents by Inventor Kathleen Kelly

Kathleen Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and apparatus for complying with predictive dialer requirements
    Publication number: 20050207548
    Abstract: Apparatus for assessing compliance with FTC/FCC predictive dialer requirements includes a predictive dialer for dialing selected calls, a call-log data record for recording data necessary to determine for a selected call by said predictive dialer whether said call meets FTC/FCC requirements for calls from a consumer telemarketer, a compliance analyzer, a data transfer agent for transferring data from the call-log data record to said compliance analyzer which is operative to analyze the transferred data to determine whether it is in compliance with said FTC/FCC requirements, and a result presentation system for generating a report to demonstrate compliance with the FTC/FCC requirements.
    Type: Application
    Filed: December 17, 2004
    Publication date: September 22, 2005
    Inventors: Mark Moore, Kathleen Kelly
  • Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 ? subunit
    Patent number: 6846911
    Abstract: Isolated proteins comprising the T-cell surface antigen CD97 ? are provided. Compositions and methods for making and detecting CD97 ? are also provided. Further, the invention provides diagnostic and therapeutic methods and compositions for medical conditions involving CD97. The inventions also provides antibody compositions that bind specifically to CD97 ? subunits.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: January 25, 2005
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Kathleen Kelly
  • Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 alpha subunit
    Publication number: 20020168361
    Abstract: Isolated proteins comprising the T-cell surface antigen CD97 a are provided. Compositions and methods for making and detecting CD97 &agr; are also provided. Further, the invention provides diagnostic and therapeutic methods and compositions for medical conditions involving CD97.
    Type: Application
    Filed: January 29, 2002
    Publication date: November 14, 2002
    Applicant: The US Secretary of the Department of Health and Human Services
    Inventor: Kathleen Kelly
  • Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian CD97 &agr; subunit
    Patent number: 6365712
    Abstract: Isolated proteins comprising the T-cell surface antigen CD97 &agr; are provided. Compositions and methods for making and detecting CD97 &agr; are also provided. Further, the invention provides diagnostic and therapeutic methods and compositions for medical conditions involving CD97.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: April 2, 2002
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventor: Kathleen Kelly